News - lenvatinib

Filter

Current filters:

lenvatinib

Popular Filters

ASCO 2014 kicks off with news on lenvatinib, Cyramza, olaparib and Recentin

ASCO 2014 kicks off with news on lenvatinib, Cyramza, olaparib and Recentin

01-06-2014

The 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) began on Friday in Chicago,…

AstraZenecaBiotechnologyCyramzaEisaiEli LillylenvatinibolaparibOncologyRecentinResearch

Eisai’s lenvatinib meets primary endpoint in Ph III thyroid cancer study

Eisai’s lenvatinib meets primary endpoint in Ph III thyroid cancer study

03-02-2014

Japanese drug major Eisai says that the Phase III SELECT trial (Study 303) of lenvatinib, an investigational…

EisailenvatinibOncologyPharmaceuticalResearch

Therapeutic effects of Eisai's lenvatinib in melanoma confirmed

12-06-2013

Japanese drug major Eisai (TYO: 4523) says that the therapeutic effects of lenvatinib, a VEGF receptor…

EisailenvatinibOncologyPharmaceuticalQuintilesResearch

Eisai files for new Halaven indication; gets orphan status for lenvatinib in EU

08-05-2013

Japanese drug major Eisai (TYO: 4523) has filed a Type II Variation application with the European Medicines…

EisaiEuropeHalavenlenvatinibOncologyPharmaceuticalRegulation

Back to top